Thus, APOBEC3B is a marker of poor prognosis for ER+ breast cancer, which strongly suggests that genetic aberrations induced by APOBEC3B contribute to breast cancer progression or resistance to treatment [10, 11]. The gene discussed is APOBEC3B; the disease is breast cancer.